Healthcare

The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...

This study investigates the global tissue diagnostics market for the period 2009 to 2017. The geographic regions are the US, Western Europe, APAC, and ROW through which the market is broadly classified by the advance stains segment and the pre-analytical segment. The study also includes a competitive analysis (SWOT), product analysis, revenue forec...

Given the importance of the changes from PPACA and the creation of the health insurance marketplaces, we are providing our online Frost.com blog on HIX in collected form for the month of September for ease of use by our subscription clients. This discussion is brought to you by our Connected Health research program. Please also follow our blog, par...

This issue of Vital Signs, released on November 22, 2013, provides overview of global IVD market dynamics, discuss growth strategy, and explore early opportunities in the African IVD market. Additionally, a company spotlight is provided for Global BioDiagnostics based in Temple, Texas. The company is focused on developing affordable diagnostic tes...

This research service presents an analysis of the endoscopy devices in focusing on Australia, South Korea and Southeast Asian market. The elderly population in Asia-Pacific is increasing at a rapid rate. The growing aging society translates to increase in lifestyle disease leading to chronic diseases and age-related surgeries. With innovations in h...

The following Vital Signs presents highlights from our attendance at Health 2.0 in Santa Clara, CA. This meeting is held every fall in the San Francisco area and is considered to be one of the premier events to gage the latest trends in disruptive health IT, particularly related to consumer health and patient engagement. We discuss our perspectives...

This issue of Vital Signs, released on October 31, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharma/Biotech, In Vitro Diagnostics, and Advanced Medical Technology.

China is predicted to become the third-largest pharmaceutical market in the world by the end of 2013 due to the governments considerable investment in the healthcare industry and the populations unmet healthcare needs. The life sciences industry is broad and involves a wide range of disciplines. This research service focuses on the trends and mar...

This issue of Vital Signs, released on October 31, 2013, provides a review of the radiology reporting market transition to technology-based solutions. Radiology reporting is an advancing area in medical imaging informatics. Additionally, a company spotlight is provided for Montage Healthcare Solutions. The company developed Montage Search and An...